North America Cancer Biopsy Market Size & Outlook
Related Markets
North America cancer biopsy market highlights
- The North America cancer biopsy market generated a revenue of USD 13,401.0 million in 2024.
- The market is expected to grow at a CAGR of 6.9% from 2025 to 2033.
- In terms of segment, kits and consumables was the largest revenue generating product in 2024.
- Instruments is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2033.
North America data book summary
| Market revenue in 2024 | USD 13,401.0 million |
| Market revenue in 2033 | USD 24,523.6 million |
| Growth rate | 6.9% (CAGR from 2025 to 2033) |
| Largest segment | Kits and consumables |
| Fastest growing segment | Instruments |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Kits and Consumables, Services |
| Key market players worldwide | Qiagen NV, Illumina Inc, Becton Dickinson & Co, ANGLE PLC, Myriad Genetics Inc, Hologic Inc, Biocept Inc, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG, Guardant Health Inc, Exact Sciences Corp, Biodesix Inc Ordinary Shares, Epigenomics AG, OncoCyte Corp, Natera Inc, Personalis Inc, Labcorp Holdings Inc, Helio Health |
Other key industry trends
- In terms of revenue, North America region accounted for 41.5% of the global cancer biopsy market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 16,110.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Biopsy Market Scope
Cancer Biopsy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Helio Health | View profile | 501-1000 | Syracuse, New York, United States, North America | https://www.helio.health/ |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Personalis Inc | View profile | 225 | 6600 Dumbarton Circle, Fremont, CA, United States, 94555 | https://www.personalis.com |
| Natera Inc | View profile | 3293 | 13011 McCallen Pass, Building A Suite 100, Austin, TX, United States, 78753 | https://www.natera.com |
| OncoCyte Corp | View profile | 46 | 15 Cushing, Irvine, CA, United States, 92618 | https://www.oncocyte.com |
| Epigenomics AG | View profile | 18 | Geneststrasse 5, Berlin, BB, Germany, 10829 | https://www.epigenomics.com |
| Biodesix Inc Ordinary Shares | View profile | 217 | 919 West Dillon Road, Louisville, CO, United States, 80301 | https://www.biodesix.com |
| Exact Sciences Corp | View profile | 6600 | 5505 Endeavor Lane, Madison, WI, United States, 53719 | https://www.exactsciences.com |
| Guardant Health Inc | View profile | 1779 | 3100 Hanover Street, Palo Alto, CA, United States, 94304 | https://www.guardanthealth.com |
| Biocept Inc | View profile | 50 | 9955 Mesa Rim Road, San Diego, CA, United States, 92121 | https://www.biocept.com |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Myriad Genetics Inc | View profile | 2700 | 320 Wakara Way, Salt Lake City, UT, United States, 84108 | https://www.myriad.com |
| ANGLE PLC | View profile | 165 | 10 Nugent Road, The Surrey Research Park, Surrey, Guildford, United Kingdom, GU2 7AF | https://www.angleplc.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
North America cancer biopsy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cancer biopsy market will help companies and investors design strategic landscapes.
Kits and consumables was the largest segment with a revenue share of 67.45% in 2024. Horizon Databook has segmented the North America cancer biopsy market based on instruments, kits and consumables, services covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to North America cancer biopsy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America cancer biopsy market databook
-
Our clientele includes a mix of cancer biopsy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America cancer biopsy market , including forecasts for subscribers. This continent databook contains high-level insights into North America cancer biopsy market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
North America cancer biopsy market size, by country, 2021-2033 (US$M)
North America Cancer Biopsy Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
